{"transactions":[{"id":4025334,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":168845,"kind":"person","name":"Phalen Michael P.","position":1,"cik":"0001483882","reported_name":"Phalen Michael P.","relationship":{"officer":true,"officer_title":"EVP & President, MedSurg"}}],"security":"Deferred Stock Units","published_at":"2018-03-01T21:37:21.000Z","date":"2018-02-28","kind":"exercise","acquired":false,"shares":2443,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Shares of common stock will be issued to the reporting person in five equal annual installments beginning on February 28, 2018, the first anniversary of the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Shares of common stock will be issued to the reporting person in five equal annual installments beginning on February 28, 2018, the first anniversary of the date of grant."}],"balance_after":9776,"derivative":{"expiration_date":"2022-02-28","underlying":"Common Stock","underlying_shares":2443},"source":{"system":"sec-edgar","filing":"0001225208-18-004948","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520818004948/doc4.xml","form_type":"4"}},{"id":4025333,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":168845,"kind":"person","name":"Phalen Michael P.","position":1,"cik":"0001483882","reported_name":"Phalen Michael P.","relationship":{"officer":true,"officer_title":"EVP & President, MedSurg"}}],"security":"Deferred Stock Units","published_at":"2018-03-01T21:37:21.000Z","date":"2018-02-28","kind":"exercise","acquired":false,"shares":5413,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Shares of common stock will be issued to the reporting person in five equal annual installments beginning on February 28, 2014, the first anniversary of the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Shares of common stock will be issued to the reporting person in five equal annual installments beginning on February 28, 2014, the first anniversary of the date of grant."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":5413},"source":{"system":"sec-edgar","filing":"0001225208-18-004948","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520818004948/doc4.xml","form_type":"4"}},{"id":4025332,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":168845,"kind":"person","name":"Phalen Michael P.","position":1,"cik":"0001483882","reported_name":"Phalen Michael P.","relationship":{"officer":true,"officer_title":"EVP & President, MedSurg"}}],"security":"Common Stock","published_at":"2018-03-01T21:37:21.000Z","date":"2018-02-28","kind":"tax_withholding","acquired":false,"shares":3493,"price":27.26,"value":95219.18,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares acquired under the Boston Scientific Global Employee Stock Purchase Plan based upon the most current data available."}],"balance_after":133373,"source":{"system":"sec-edgar","filing":"0001225208-18-004948","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520818004948/doc4.xml","form_type":"4"}},{"id":4025331,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":168845,"kind":"person","name":"Phalen Michael P.","position":1,"cik":"0001483882","reported_name":"Phalen Michael P.","relationship":{"officer":true,"officer_title":"EVP & President, MedSurg"}}],"security":"Common Stock","published_at":"2018-03-01T21:37:21.000Z","date":"2018-02-28","kind":"exercise","acquired":true,"shares":2443,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares acquired under the Boston Scientific Global Employee Stock Purchase Plan based upon the most current data available."}],"balance_after":136866,"source":{"system":"sec-edgar","filing":"0001225208-18-004948","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520818004948/doc4.xml","form_type":"4"}},{"id":4025330,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":168845,"kind":"person","name":"Phalen Michael P.","position":1,"cik":"0001483882","reported_name":"Phalen Michael P.","relationship":{"officer":true,"officer_title":"EVP & President, MedSurg"}}],"security":"Common Stock","published_at":"2018-03-01T21:37:21.000Z","date":"2018-02-28","kind":"exercise","acquired":true,"shares":5413,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares acquired under the Boston Scientific Global Employee Stock Purchase Plan based upon the most current data available."}],"balance_after":134423,"source":{"system":"sec-edgar","filing":"0001225208-18-004948","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520818004948/doc4.xml","form_type":"4"}},{"id":4035217,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":168845,"kind":"person","name":"Phalen Michael P.","position":1,"cik":"0001483882","reported_name":"Phalen Michael P.","relationship":{"officer":true,"officer_title":"EVP & President, MedSurg"}}],"security":"Deferred Stock Units","published_at":"2018-02-26T22:42:43.000Z","date":"2018-02-24","kind":"exercise","acquired":false,"shares":3440,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Shares of common stock will be issued to the reporting person in five equal annual installments beginning on February 24, 2015, the first anniversary of the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Shares of common stock will be issued to the reporting person in five equal annual installments beginning on February 24, 2015, the first anniversary of the date of grant."}],"balance_after":3441,"derivative":{"exercise_price":0,"expiration_date":"2019-02-24","underlying":"Common Stock","underlying_shares":3440},"source":{"system":"sec-edgar","filing":"0001225208-18-004204","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520818004204/doc4.xml","form_type":"4"}},{"id":4035216,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":168845,"kind":"person","name":"Phalen Michael P.","position":1,"cik":"0001483882","reported_name":"Phalen Michael P.","relationship":{"officer":true,"officer_title":"EVP & President, MedSurg"}}],"security":"Deferred Stock Units","published_at":"2018-02-26T22:42:43.000Z","date":"2018-02-23","kind":"exercise","acquired":false,"shares":2452,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Shares of common stock will be issued to the reporting person in five equal annual installments beginning on February 23, 2016, the first anniversary of the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Shares of common stock will be issued to the reporting person in five equal annual installments beginning on February 23, 2016, the first anniversary of the date of grant."}],"balance_after":4906,"derivative":{"expiration_date":"2020-02-23","underlying":"Common Stock","underlying_shares":2452},"source":{"system":"sec-edgar","filing":"0001225208-18-004204","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520818004204/doc4.xml","form_type":"4"}},{"id":4035215,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":168845,"kind":"person","name":"Phalen Michael P.","position":1,"cik":"0001483882","reported_name":"Phalen Michael P.","relationship":{"officer":true,"officer_title":"EVP & President, MedSurg"}}],"security":"Common Stock","published_at":"2018-02-26T22:42:43.000Z","date":"2018-02-24","kind":"tax_withholding","acquired":false,"shares":1530,"price":27.2,"value":41616.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares acquired under the Boston Scientific Global Employee Stock Purchase Plan based upon the most current data available."}],"balance_after":129010,"source":{"system":"sec-edgar","filing":"0001225208-18-004204","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520818004204/doc4.xml","form_type":"4"}},{"id":4035214,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":168845,"kind":"person","name":"Phalen Michael P.","position":1,"cik":"0001483882","reported_name":"Phalen Michael P.","relationship":{"officer":true,"officer_title":"EVP & President, MedSurg"}}],"security":"Common Stock","published_at":"2018-02-26T22:42:43.000Z","date":"2018-02-24","kind":"exercise","acquired":true,"shares":3440,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares acquired under the Boston Scientific Global Employee Stock Purchase Plan based upon the most current data available."}],"balance_after":130540,"source":{"system":"sec-edgar","filing":"0001225208-18-004204","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520818004204/doc4.xml","form_type":"4"}},{"id":4035213,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":168845,"kind":"person","name":"Phalen Michael P.","position":1,"cik":"0001483882","reported_name":"Phalen Michael P.","relationship":{"officer":true,"officer_title":"EVP & President, MedSurg"}}],"security":"Common Stock","published_at":"2018-02-26T22:42:43.000Z","date":"2018-02-23","kind":"tax_withholding","acquired":false,"shares":1090,"price":27.2,"value":29648.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares acquired under the Boston Scientific Global Employee Stock Purchase Plan based upon the most current data available."}],"balance_after":127100,"source":{"system":"sec-edgar","filing":"0001225208-18-004204","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520818004204/doc4.xml","form_type":"4"}},{"id":4035212,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":168845,"kind":"person","name":"Phalen Michael P.","position":1,"cik":"0001483882","reported_name":"Phalen Michael P.","relationship":{"officer":true,"officer_title":"EVP & President, MedSurg"}}],"security":"Common Stock","published_at":"2018-02-26T22:42:43.000Z","date":"2018-02-23","kind":"exercise","acquired":true,"shares":2452,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares acquired under the Boston Scientific Global Employee Stock Purchase Plan based upon the most current data available."}],"balance_after":128190,"source":{"system":"sec-edgar","filing":"0001225208-18-004204","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520818004204/doc4.xml","form_type":"4"}},{"id":4038081,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":168845,"kind":"person","name":"Phalen Michael P.","position":1,"cik":"0001483882","reported_name":"Phalen Michael P.","relationship":{"officer":true,"officer_title":"EVP & President, MedSurg"}}],"security":"Deferred Stock Units","published_at":"2018-02-23T21:13:37.000Z","date":"2018-02-22","kind":"exercise","acquired":false,"shares":2462,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Shares of common stock will be issued to the reporting person in five equal annual installments beginning on February 22, 2017, the first anniversary of the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Shares of common stock will be issued to the reporting person in five equal annual installments beginning on February 22, 2017, the first anniversary of the date of grant."}],"balance_after":7387,"derivative":{"expiration_date":"2021-02-22","underlying":"Common Stock","underlying_shares":2462},"source":{"system":"sec-edgar","filing":"0001225208-18-004010","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520818004010/doc4.xml","form_type":"4"}},{"id":4038080,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":168845,"kind":"person","name":"Phalen Michael P.","position":1,"cik":"0001483882","reported_name":"Phalen Michael P.","relationship":{"officer":true,"officer_title":"EVP & President, MedSurg"}}],"security":"Common Stock","published_at":"2018-02-23T21:13:37.000Z","date":"2018-02-22","kind":"tax_withholding","acquired":false,"shares":944,"price":26.48,"value":24997.12,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares acquired under the Boston Scientific Global Employee Stock Purchase Plan based upon the most current data available."}],"balance_after":125738,"source":{"system":"sec-edgar","filing":"0001225208-18-004010","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520818004010/doc4.xml","form_type":"4"}},{"id":4038079,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":168845,"kind":"person","name":"Phalen Michael P.","position":1,"cik":"0001483882","reported_name":"Phalen Michael P.","relationship":{"officer":true,"officer_title":"EVP & President, MedSurg"}}],"security":"Common Stock","published_at":"2018-02-23T21:13:37.000Z","date":"2018-02-22","kind":"exercise","acquired":true,"shares":2462,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares acquired under the Boston Scientific Global Employee Stock Purchase Plan based upon the most current data available."}],"balance_after":126682,"source":{"system":"sec-edgar","filing":"0001225208-18-004010","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520818004010/doc4.xml","form_type":"4"}},{"id":4060669,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":168845,"kind":"person","name":"Phalen Michael P.","position":1,"cik":"0001483882","reported_name":"Phalen Michael P.","relationship":{"officer":true,"officer_title":"EVP & President, MedSurg"}}],"security":"Performance Share Units","published_at":"2018-02-14T21:32:14.000Z","date":"2018-02-12","kind":"grant","acquired":true,"shares":11926,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each performance share unit represents the Company's commitment to issue one share of Boston Scientific common stock."},{"field":"shares","element":"transactionShares","label":"F4","text":"On February 28, 2017, the reporting person was awarded a target number of performance share units under the Company's 2017 Free Cash Flow Performance Share Program, the actual number of which to be earned by the reporting person based on the Company's 2017 adjusted free cash flow measured against its 2017 financial plan over the one-year performance period ending December 31, 2017 and subject to the completion of a three-year individual service period (inclusive of the performance period). On February 12, 2018, the number of the target performance share units as to which the performance criteria had been satisfied was determined. The performance share units so determined will vest in whole upon the completion of the individual service period that ends on December 31, 2019."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"On February 28, 2017, the reporting person was awarded a target number of performance share units under the Company's 2017 Free Cash Flow Performance Share Program, the actual number of which to be earned by the reporting person based on the Company's 2017 adjusted free cash flow measured against its 2017 financial plan over the one-year performance period ending December 31, 2017 and subject to the completion of a three-year individual service period (inclusive of the performance period). On February 12, 2018, the number of the target performance share units as to which the performance criteria had been satisfied was determined. The performance share units so determined will vest in whole upon the completion of the individual service period that ends on December 31, 2019."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"On February 28, 2017, the reporting person was awarded a target number of performance share units under the Company's 2017 Free Cash Flow Performance Share Program, the actual number of which to be earned by the reporting person based on the Company's 2017 adjusted free cash flow measured against its 2017 financial plan over the one-year performance period ending December 31, 2017 and subject to the completion of a three-year individual service period (inclusive of the performance period). On February 12, 2018, the number of the target performance share units as to which the performance criteria had been satisfied was determined. The performance share units so determined will vest in whole upon the completion of the individual service period that ends on December 31, 2019."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"On February 28, 2017, the reporting person was awarded a target number of performance share units under the Company's 2017 Free Cash Flow Performance Share Program, the actual number of which to be earned by the reporting person based on the Company's 2017 adjusted free cash flow measured against its 2017 financial plan over the one-year performance period ending December 31, 2017 and subject to the completion of a three-year individual service period (inclusive of the performance period). On February 12, 2018, the number of the target performance share units as to which the performance criteria had been satisfied was determined. The performance share units so determined will vest in whole upon the completion of the individual service period that ends on December 31, 2019."}],"balance_after":11926,"derivative":{"exercise_date":"2019-12-31","expiration_date":"2019-12-31","underlying":"Common Stock","underlying_shares":11926},"source":{"system":"sec-edgar","filing":"0001225208-18-002898","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520818002898/doc4.xml","form_type":"4"}},{"id":4060668,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":168845,"kind":"person","name":"Phalen Michael P.","position":1,"cik":"0001483882","reported_name":"Phalen Michael P.","relationship":{"officer":true,"officer_title":"EVP & President, MedSurg"}}],"security":"Common Stock","published_at":"2018-02-14T21:32:14.000Z","date":"2018-02-12","kind":"tax_withholding","acquired":false,"shares":7223,"price":26.18,"value":189098.14,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares acquired under the Boston Scientific Global Employee Stock Purchase Plan based upon the most current data available."}],"balance_after":124220,"source":{"system":"sec-edgar","filing":"0001225208-18-002898","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520818002898/doc4.xml","form_type":"4"}},{"id":4060667,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":168845,"kind":"person","name":"Phalen Michael P.","position":1,"cik":"0001483882","reported_name":"Phalen Michael P.","relationship":{"officer":true,"officer_title":"EVP & President, MedSurg"}}],"security":"Common Stock","published_at":"2018-02-14T21:32:14.000Z","date":"2018-02-12","kind":"grant","acquired":true,"shares":24524,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On February 23, 2015, the reporting person was awarded a target number of performance share units under the Company's 2015 Total Shareholder Return Performance Share Program, the actual number of which to be earned by the reporting person was based on the Company's total shareholder return performance percentile relative to that of the other companies in the S&P 500 Healthcare Index over the three annual performance cycles comprising the three-year period ended December 31, 2017 and was subject to the completion of the concurrent three-year individual service period. On February 12, 2018, the number of the target performance share units as to which the performance criteria had been satisfied was determined and the individual service period was satisfied."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares acquired under the Boston Scientific Global Employee Stock Purchase Plan based upon the most current data available."}],"balance_after":131443,"source":{"system":"sec-edgar","filing":"0001225208-18-002898","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520818002898/doc4.xml","form_type":"4"}},{"id":4114570,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":168845,"kind":"person","name":"Phalen Michael P.","position":1,"cik":"0001483882","reported_name":"Phalen Michael P.","relationship":{"officer":true,"officer_title":"EVP & President, MedSurg"}}],"security":"Performance Share Units","published_at":"2018-01-04T00:53:19.000Z","date":"2018-01-01","kind":"exercise","acquired":false,"shares":13341,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F6","text":"Each performance share unit represents the Company's commitment to issue one share of Boston Scientific common stock."},{"field":"shares","element":"transactionShares","label":"F4","text":"On February 23, 2015, the reporting person was awarded a target number of performance share units under the Company's 2015 Free Cash Flow Performance Share Program, the actual number of which to be earned by the reporting person based on the Company's 2015 adjusted free cash flow measured against its 2015 financial plan over the one-year performance period ending December 31, 2015 and subject to the completion of a three-year individual service period (inclusive of the performance period). On February 22, 2016, the number of the target performance share units as to which the performance criteria had been satisfied was determined. The performance share units so determined vested in whole upon the completion of the individual service period that ended on December 31, 2017."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"On February 23, 2015, the reporting person was awarded a target number of performance share units under the Company's 2015 Free Cash Flow Performance Share Program, the actual number of which to be earned by the reporting person based on the Company's 2015 adjusted free cash flow measured against its 2015 financial plan over the one-year performance period ending December 31, 2015 and subject to the completion of a three-year individual service period (inclusive of the performance period). On February 22, 2016, the number of the target performance share units as to which the performance criteria had been satisfied was determined. The performance share units so determined vested in whole upon the completion of the individual service period that ended on December 31, 2017."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"On February 23, 2015, the reporting person was awarded a target number of performance share units under the Company's 2015 Free Cash Flow Performance Share Program, the actual number of which to be earned by the reporting person based on the Company's 2015 adjusted free cash flow measured against its 2015 financial plan over the one-year performance period ending December 31, 2015 and subject to the completion of a three-year individual service period (inclusive of the performance period). On February 22, 2016, the number of the target performance share units as to which the performance criteria had been satisfied was determined. The performance share units so determined vested in whole upon the completion of the individual service period that ended on December 31, 2017."}],"balance_after":0,"derivative":{"exercise_date":"2017-12-31","expiration_date":"2017-12-31","underlying":"Common Stock","underlying_shares":13341},"source":{"system":"sec-edgar","filing":"0001225208-18-000493","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520818000493/doc4.xml","form_type":"4"}},{"id":4114569,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":168845,"kind":"person","name":"Phalen Michael P.","position":1,"cik":"0001483882","reported_name":"Phalen Michael P.","relationship":{"officer":true,"officer_title":"EVP & President, MedSurg"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-01-04T00:53:19.000Z","date":"2017-12-29","kind":"exercise","acquired":false,"shares":15835,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a pre-established Rule 10b5-1 trading plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 28, 2012, the first anniversary of the date of grant."}],"balance_after":0,"derivative":{"exercise_price":7.16,"expiration_date":"2021-02-28","underlying":"Common Stock","underlying_shares":15835},"source":{"system":"sec-edgar","filing":"0001225208-18-000493","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520818000493/doc4.xml","form_type":"4"}},{"id":4114568,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":168845,"kind":"person","name":"Phalen Michael P.","position":1,"cik":"0001483882","reported_name":"Phalen Michael P.","relationship":{"officer":true,"officer_title":"EVP & President, MedSurg"}}],"security":"Common Stock","published_at":"2018-01-04T00:53:19.000Z","date":"2018-01-01","kind":"tax_withholding","acquired":false,"shares":4578,"price":24.79,"value":113488.62,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares acquired under the Boston Scientific Global Employee Stock Purchase Plan based upon the most current data available."}],"balance_after":106673,"source":{"system":"sec-edgar","filing":"0001225208-18-000493","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520818000493/doc4.xml","form_type":"4"}},{"id":4114567,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":168845,"kind":"person","name":"Phalen Michael P.","position":1,"cik":"0001483882","reported_name":"Phalen Michael P.","relationship":{"officer":true,"officer_title":"EVP & President, MedSurg"}}],"security":"Common Stock","published_at":"2018-01-04T00:53:19.000Z","date":"2018-01-01","kind":"exercise","acquired":true,"shares":13341,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"On February 23, 2015, the reporting person was awarded a target number of performance share units under the Company's 2015 Free Cash Flow Performance Share Program, the actual number of which to be earned by the reporting person based on the Company's 2015 adjusted free cash flow measured against its 2015 financial plan over the one-year performance period ending December 31, 2015 and subject to the completion of a three-year individual service period (inclusive of the performance period). On February 22, 2016, the number of the target performance share units as to which the performance criteria had been satisfied was determined. The performance share units so determined vested in whole upon the completion of the individual service period that ended on December 31, 2017."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares acquired under the Boston Scientific Global Employee Stock Purchase Plan based upon the most current data available."}],"balance_after":111251,"source":{"system":"sec-edgar","filing":"0001225208-18-000493","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520818000493/doc4.xml","form_type":"4"}},{"id":4114566,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":168845,"kind":"person","name":"Phalen Michael P.","position":1,"cik":"0001483882","reported_name":"Phalen Michael P.","relationship":{"officer":true,"officer_title":"EVP & President, MedSurg"}}],"security":"Common Stock","published_at":"2018-01-04T00:53:19.000Z","date":"2017-12-29","kind":"sale","acquired":false,"shares":15835,"price":25.252,"value":399865.42,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a pre-established Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $25.24 to $25.26, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares acquired under the Boston Scientific Global Employee Stock Purchase Plan based upon the most current data available."}],"balance_after":97910,"source":{"system":"sec-edgar","filing":"0001225208-18-000493","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520818000493/doc4.xml","form_type":"4"}},{"id":4114565,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":168845,"kind":"person","name":"Phalen Michael P.","position":1,"cik":"0001483882","reported_name":"Phalen Michael P.","relationship":{"officer":true,"officer_title":"EVP & President, MedSurg"}}],"security":"Common Stock","published_at":"2018-01-04T00:53:19.000Z","date":"2017-12-29","kind":"exercise","acquired":true,"shares":15835,"price":7.16,"value":113378.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a pre-established Rule 10b5-1 trading plan."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares acquired under the Boston Scientific Global Employee Stock Purchase Plan based upon the most current data available."}],"balance_after":113745,"source":{"system":"sec-edgar","filing":"0001225208-18-000493","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520818000493/doc4.xml","form_type":"4"}},{"id":4148235,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":168845,"kind":"person","name":"Phalen Michael P.","position":1,"cik":"0001483882","reported_name":"Phalen Michael P.","relationship":{"officer":true,"officer_title":"EVP & President, MedSurg"}}],"security":"Stock Option (Right to Buy)","published_at":"2017-11-30T21:13:05.000Z","date":"2017-11-29","kind":"exercise","acquired":false,"shares":15500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 28, 2012, the first anniversary of the date of grant."}],"balance_after":15835,"derivative":{"exercise_price":7.16,"expiration_date":"2021-02-28","underlying":"Common Stock","underlying_shares":15500},"source":{"system":"sec-edgar","filing":"0001225208-17-017780","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520817017780/doc4.xml","form_type":"4"}},{"id":4148234,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":168845,"kind":"person","name":"Phalen Michael P.","position":1,"cik":"0001483882","reported_name":"Phalen Michael P.","relationship":{"officer":true,"officer_title":"EVP & President, MedSurg"}}],"security":"Common Stock","published_at":"2017-11-30T21:13:05.000Z","date":"2017-11-29","kind":"sale","acquired":false,"shares":15500,"price":26.6614,"value":413251.7,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $26.6210 to $26.72, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes shares acquired under the Boston Scientific Global Employee Stock Purchase Plan based upon the most current data available."}],"balance_after":97910,"source":{"system":"sec-edgar","filing":"0001225208-17-017780","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520817017780/doc4.xml","form_type":"4"}},{"id":4148233,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":168845,"kind":"person","name":"Phalen Michael P.","position":1,"cik":"0001483882","reported_name":"Phalen Michael P.","relationship":{"officer":true,"officer_title":"EVP & President, MedSurg"}}],"security":"Common Stock","published_at":"2017-11-30T21:13:05.000Z","date":"2017-11-29","kind":"exercise","acquired":true,"shares":15500,"price":7.16,"value":110980.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes shares acquired under the Boston Scientific Global Employee Stock Purchase Plan based upon the most current data available."}],"balance_after":113410,"source":{"system":"sec-edgar","filing":"0001225208-17-017780","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520817017780/doc4.xml","form_type":"4"}},{"id":4148232,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":168845,"kind":"person","name":"Phalen Michael P.","position":1,"cik":"0001483882","reported_name":"Phalen Michael P.","relationship":{"officer":true,"officer_title":"EVP & President, MedSurg"}}],"security":"Common Stock","published_at":"2017-11-30T21:13:05.000Z","date":"2017-11-10","kind":"gift","acquired":false,"shares":4756,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes shares acquired under the Boston Scientific Global Employee Stock Purchase Plan based upon the most current data available."}],"balance_after":97910,"source":{"system":"sec-edgar","filing":"0001225208-17-017780","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520817017780/doc4.xml","form_type":"4"}},{"id":4178876,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":168845,"kind":"person","name":"Phalen Michael P.","position":1,"cik":"0001483882","reported_name":"Phalen Michael P.","relationship":{"officer":true,"officer_title":"EVP & President, MedSurg"}}],"security":"Stock Option (Right to Buy)","published_at":"2017-10-30T20:02:11.000Z","date":"2017-10-30","kind":"exercise","acquired":false,"shares":15500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 28, 2012, the first anniversary of the grant."}],"balance_after":31335,"derivative":{"exercise_price":7.16,"expiration_date":"2021-02-28","underlying":"Common Stock","underlying_shares":15500},"source":{"system":"sec-edgar","filing":"0001225208-17-016660","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520817016660/doc4.xml","form_type":"4"}},{"id":4178875,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":168845,"kind":"person","name":"Phalen Michael P.","position":1,"cik":"0001483882","reported_name":"Phalen Michael P.","relationship":{"officer":true,"officer_title":"EVP & President, MedSurg"}}],"security":"Common Stock","published_at":"2017-10-30T20:02:11.000Z","date":"2017-10-30","kind":"sale","acquired":false,"shares":15500,"price":28.4224,"value":440547.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $28.3963 to $28.44, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares acquired under the Boston Scientific Global Employee Stock Purchase Plan based upon the most current data available."}],"balance_after":102666,"source":{"system":"sec-edgar","filing":"0001225208-17-016660","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520817016660/doc4.xml","form_type":"4"}},{"id":4178874,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":168845,"kind":"person","name":"Phalen Michael P.","position":1,"cik":"0001483882","reported_name":"Phalen Michael P.","relationship":{"officer":true,"officer_title":"EVP & President, MedSurg"}}],"security":"Common Stock","published_at":"2017-10-30T20:02:11.000Z","date":"2017-10-30","kind":"exercise","acquired":true,"shares":15500,"price":7.16,"value":110980.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares acquired under the Boston Scientific Global Employee Stock Purchase Plan based upon the most current data available."}],"balance_after":118166,"source":{"system":"sec-edgar","filing":"0001225208-17-016660","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520817016660/doc4.xml","form_type":"4"}},{"id":4198371,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":168845,"kind":"person","name":"Phalen Michael P.","position":1,"cik":"0001483882","reported_name":"Phalen Michael P.","relationship":{"officer":true,"officer_title":"EVP & President, MedSurg"}}],"security":"Stock Option (Right to Buy)","published_at":"2017-10-02T20:15:31.000Z","date":"2017-09-29","kind":"exercise","acquired":false,"shares":15500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 28, 2012, the first anniversary of the grant."}],"balance_after":46835,"derivative":{"exercise_price":7.16,"expiration_date":"2021-02-28","underlying":"Common Stock","underlying_shares":15500},"source":{"system":"sec-edgar","filing":"0001225208-17-015573","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520817015573/doc4.xml","form_type":"4"}},{"id":4198370,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":168845,"kind":"person","name":"Phalen Michael P.","position":1,"cik":"0001483882","reported_name":"Phalen Michael P.","relationship":{"officer":true,"officer_title":"EVP & President, MedSurg"}}],"security":"Common Stock","published_at":"2017-10-02T20:15:31.000Z","date":"2017-09-29","kind":"sale","acquired":false,"shares":15500,"price":28.7185,"value":445136.75,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $28.70 to $28.735, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares acquired under the Boston Scientific Global Employee Stock Purchase Plan based upon the most current data available."}],"balance_after":102666,"source":{"system":"sec-edgar","filing":"0001225208-17-015573","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520817015573/doc4.xml","form_type":"4"}},{"id":4198369,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":168845,"kind":"person","name":"Phalen Michael P.","position":1,"cik":"0001483882","reported_name":"Phalen Michael P.","relationship":{"officer":true,"officer_title":"EVP & President, MedSurg"}}],"security":"Common Stock","published_at":"2017-10-02T20:15:31.000Z","date":"2017-09-29","kind":"exercise","acquired":true,"shares":15500,"price":7.16,"value":110980.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares acquired under the Boston Scientific Global Employee Stock Purchase Plan based upon the most current data available."}],"balance_after":118166,"source":{"system":"sec-edgar","filing":"0001225208-17-015573","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520817015573/doc4.xml","form_type":"4"}},{"id":4222038,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":168845,"kind":"person","name":"Phalen Michael P.","position":1,"cik":"0001483882","reported_name":"Phalen Michael P.","relationship":{"officer":true,"officer_title":"EVP & President, MedSurg"}}],"security":"Stock Option (Right to Buy)","published_at":"2017-08-30T20:10:10.000Z","date":"2017-08-29","kind":"exercise","acquired":false,"shares":15500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 28, 2012, the first anniversary of the grant."}],"balance_after":62335,"derivative":{"exercise_price":7.16,"expiration_date":"2021-02-28","underlying":"Common Stock","underlying_shares":15500},"source":{"system":"sec-edgar","filing":"0001225208-17-014413","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520817014413/doc4.xml","form_type":"4"}},{"id":4222037,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":168845,"kind":"person","name":"Phalen Michael P.","position":1,"cik":"0001483882","reported_name":"Phalen Michael P.","relationship":{"officer":true,"officer_title":"EVP & President, MedSurg"}}],"security":"Common Stock","published_at":"2017-08-30T20:10:10.000Z","date":"2017-08-29","kind":"sale","acquired":false,"shares":15500,"price":26.8748,"value":416559.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $26.865 to $26.895, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares acquired under the Boston Scientific Global Employee Stock Purchase Plan based upon the most current data available."}],"balance_after":102666,"source":{"system":"sec-edgar","filing":"0001225208-17-014413","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520817014413/doc4.xml","form_type":"4"}},{"id":4222036,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":168845,"kind":"person","name":"Phalen Michael P.","position":1,"cik":"0001483882","reported_name":"Phalen Michael P.","relationship":{"officer":true,"officer_title":"EVP & President, MedSurg"}}],"security":"Common Stock","published_at":"2017-08-30T20:10:10.000Z","date":"2017-08-29","kind":"exercise","acquired":true,"shares":15500,"price":7.16,"value":110980.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares acquired under the Boston Scientific Global Employee Stock Purchase Plan based upon the most current data available."}],"balance_after":118166,"source":{"system":"sec-edgar","filing":"0001225208-17-014413","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520817014413/doc4.xml","form_type":"4"}},{"id":4247805,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":168845,"kind":"person","name":"Phalen Michael P.","position":1,"cik":"0001483882","reported_name":"Phalen Michael P.","relationship":{"officer":true,"officer_title":"EVP & President, MedSurg"}}],"security":"Stock Option (Right to Buy)","published_at":"2017-08-01T20:49:00.000Z","date":"2017-07-31","kind":"exercise","acquired":false,"shares":15500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 28, 2012, the first anniversary of the grant"}],"balance_after":77835,"derivative":{"exercise_price":7.16,"expiration_date":"2021-02-28","underlying":"Common Stock","underlying_shares":15500},"source":{"system":"sec-edgar","filing":"0001225208-17-013084","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520817013084/doc4.xml","form_type":"4"}},{"id":4247804,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":168845,"kind":"person","name":"Phalen Michael P.","position":1,"cik":"0001483882","reported_name":"Phalen Michael P.","relationship":{"officer":true,"officer_title":"EVP & President, MedSurg"}}],"security":"Common Stock","published_at":"2017-08-01T20:49:00.000Z","date":"2017-07-31","kind":"sale","acquired":false,"shares":15500,"price":27.1317,"value":420541.35,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $27.121 to $27.15, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares acquired under the Boston Scientific Global Employee Stock Purchase Plan based upon the most current data available."}],"balance_after":101919,"source":{"system":"sec-edgar","filing":"0001225208-17-013084","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520817013084/doc4.xml","form_type":"4"}},{"id":4247803,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":168845,"kind":"person","name":"Phalen Michael P.","position":1,"cik":"0001483882","reported_name":"Phalen Michael P.","relationship":{"officer":true,"officer_title":"EVP & President, MedSurg"}}],"security":"Common Stock","published_at":"2017-08-01T20:49:00.000Z","date":"2017-07-31","kind":"exercise","acquired":true,"shares":15500,"price":7.16,"value":110980.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares acquired under the Boston Scientific Global Employee Stock Purchase Plan based upon the most current data available."}],"balance_after":117419,"source":{"system":"sec-edgar","filing":"0001225208-17-013084","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520817013084/doc4.xml","form_type":"4"}},{"id":4270597,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":168845,"kind":"person","name":"Phalen Michael P.","position":1,"cik":"0001483882","reported_name":"Phalen Michael P.","relationship":{"officer":true,"officer_title":"EVP & President, MedSurg"}}],"security":"Stock Option (Right to Buy)","published_at":"2017-06-29T21:15:03.000Z","date":"2017-06-29","kind":"exercise","acquired":false,"shares":15500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 28, 2012, the first anniversary of the grant."}],"balance_after":93335,"derivative":{"exercise_price":7.16,"expiration_date":"2021-02-28","underlying":"Common Stock","underlying_shares":15500},"source":{"system":"sec-edgar","filing":"0001225208-17-011676","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520817011676/doc4.xml","form_type":"4"}},{"id":4270596,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":168845,"kind":"person","name":"Phalen Michael P.","position":1,"cik":"0001483882","reported_name":"Phalen Michael P.","relationship":{"officer":true,"officer_title":"EVP & President, MedSurg"}}],"security":"Common Stock","published_at":"2017-06-29T21:15:03.000Z","date":"2017-06-29","kind":"sale","acquired":false,"shares":15500,"price":28.0187,"value":434289.85,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $27.98 to $28.08, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares acquired under the Boston Scientific Global Employee Stock Purchase Plan based upon the most current data available."}],"balance_after":101919,"source":{"system":"sec-edgar","filing":"0001225208-17-011676","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520817011676/doc4.xml","form_type":"4"}},{"id":4270595,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":168845,"kind":"person","name":"Phalen Michael P.","position":1,"cik":"0001483882","reported_name":"Phalen Michael P.","relationship":{"officer":true,"officer_title":"EVP & President, MedSurg"}}],"security":"Common Stock","published_at":"2017-06-29T21:15:03.000Z","date":"2017-06-29","kind":"exercise","acquired":true,"shares":15500,"price":7.16,"value":110980.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares acquired under the Boston Scientific Global Employee Stock Purchase Plan based upon the most current data available."}],"balance_after":117419,"source":{"system":"sec-edgar","filing":"0001225208-17-011676","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520817011676/doc4.xml","form_type":"4"}},{"id":4301943,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":168845,"kind":"person","name":"Phalen Michael P.","position":1,"cik":"0001483882","reported_name":"Phalen Michael P.","relationship":{"officer":true,"officer_title":"EVP & President, MedSurg"}}],"security":"Stock Option (Right to Buy)","published_at":"2017-05-30T20:15:27.000Z","date":"2017-05-30","kind":"exercise","acquired":false,"shares":15500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 28, 2012, the first anniversary of the grant."}],"balance_after":108835,"derivative":{"exercise_price":7.16,"expiration_date":"2021-02-28","underlying":"Common Stock","underlying_shares":15500},"source":{"system":"sec-edgar","filing":"0001225208-17-010514","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520817010514/doc4.xml","form_type":"4"}},{"id":4301942,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":168845,"kind":"person","name":"Phalen Michael P.","position":1,"cik":"0001483882","reported_name":"Phalen Michael P.","relationship":{"officer":true,"officer_title":"EVP & President, MedSurg"}}],"security":"Common Stock","published_at":"2017-05-30T20:15:27.000Z","date":"2017-05-30","kind":"sale","acquired":false,"shares":15500,"price":27.2496,"value":422368.8,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $27.23 to $27.2717, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares acquired under the Boston Scientific Global Employee Stock Purchase Plan based upon the most current data available."}],"balance_after":101919,"source":{"system":"sec-edgar","filing":"0001225208-17-010514","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520817010514/doc4.xml","form_type":"4"}},{"id":4301941,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":168845,"kind":"person","name":"Phalen Michael P.","position":1,"cik":"0001483882","reported_name":"Phalen Michael P.","relationship":{"officer":true,"officer_title":"EVP & President, MedSurg"}}],"security":"Common Stock","published_at":"2017-05-30T20:15:27.000Z","date":"2017-05-30","kind":"exercise","acquired":true,"shares":15500,"price":7.16,"value":110980.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares acquired under the Boston Scientific Global Employee Stock Purchase Plan based upon the most current data available."}],"balance_after":117419,"source":{"system":"sec-edgar","filing":"0001225208-17-010514","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520817010514/doc4.xml","form_type":"4"}},{"id":4338930,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":168845,"kind":"person","name":"Phalen Michael P.","position":1,"cik":"0001483882","reported_name":"Phalen Michael P.","relationship":{"officer":true,"officer_title":"EVP & President, MedSurg"}}],"security":"Stock Option (Right to Buy)","published_at":"2017-05-02T20:11:30.000Z","date":"2017-05-01","kind":"exercise","acquired":false,"shares":15500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 28, 2012, the first anniversary of the grant."}],"balance_after":124335,"derivative":{"exercise_price":7.16,"expiration_date":"2021-02-28","underlying":"Common Stock","underlying_shares":15500},"source":{"system":"sec-edgar","filing":"0001225208-17-008857","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520817008857/doc4.xml","form_type":"4"}},{"id":4338929,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":168845,"kind":"person","name":"Phalen Michael P.","position":1,"cik":"0001483882","reported_name":"Phalen Michael P.","relationship":{"officer":true,"officer_title":"EVP & President, MedSurg"}}],"security":"Common Stock","published_at":"2017-05-02T20:11:30.000Z","date":"2017-05-01","kind":"sale","acquired":false,"shares":15500,"price":26.3728,"value":408778.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares acquired under the Boston Scientific Global Employee Stock Purchase Plan based upon the most current data available."}],"balance_after":101919,"source":{"system":"sec-edgar","filing":"0001225208-17-008857","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520817008857/doc4.xml","form_type":"4"}},{"id":4338928,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":168845,"kind":"person","name":"Phalen Michael P.","position":1,"cik":"0001483882","reported_name":"Phalen Michael P.","relationship":{"officer":true,"officer_title":"EVP & President, MedSurg"}}],"security":"Common Stock","published_at":"2017-05-02T20:11:30.000Z","date":"2017-05-01","kind":"exercise","acquired":true,"shares":15500,"price":7.16,"value":110980.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares acquired under the Boston Scientific Global Employee Stock Purchase Plan based upon the most current data available."}],"balance_after":117419,"source":{"system":"sec-edgar","filing":"0001225208-17-008857","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520817008857/doc4.xml","form_type":"4"}},{"id":4343839,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":168845,"kind":"person","name":"Phalen Michael P.","position":1,"cik":"0001483882","reported_name":"Phalen Michael P.","relationship":{"officer":true,"officer_title":"EVP & President, MedSurg"}}],"security":"Stock Option (Right to Buy)","published_at":"2017-04-27T20:10:21.000Z","date":"2017-04-26","kind":"exercise","acquired":false,"shares":34773,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 12, 2009. This option is fully vested."}],"balance_after":0,"derivative":{"exercise_price":12.52,"expiration_date":"2018-02-12","underlying":"Common Stock","underlying_shares":34773},"source":{"system":"sec-edgar","filing":"0001225208-17-008530","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520817008530/doc4.xml","form_type":"4"}},{"id":4343838,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":168845,"kind":"person","name":"Phalen Michael P.","position":1,"cik":"0001483882","reported_name":"Phalen Michael P.","relationship":{"officer":true,"officer_title":"EVP & President, MedSurg"}}],"security":"Common Stock","published_at":"2017-04-27T20:10:21.000Z","date":"2017-04-26","kind":"sale","acquired":false,"shares":34773,"price":26,"value":904098.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares acquired under the Boston Scientific Global Employee Stock Purchase Plan based upon the most current data available."}],"balance_after":101919,"source":{"system":"sec-edgar","filing":"0001225208-17-008530","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520817008530/doc4.xml","form_type":"4"}},{"id":4343837,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":168845,"kind":"person","name":"Phalen Michael P.","position":1,"cik":"0001483882","reported_name":"Phalen Michael P.","relationship":{"officer":true,"officer_title":"EVP & President, MedSurg"}}],"security":"Common Stock","published_at":"2017-04-27T20:10:21.000Z","date":"2017-04-26","kind":"exercise","acquired":true,"shares":34773,"price":12.52,"value":435357.96,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares acquired under the Boston Scientific Global Employee Stock Purchase Plan based upon the most current data available."}],"balance_after":136692,"source":{"system":"sec-edgar","filing":"0001225208-17-008530","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520817008530/doc4.xml","form_type":"4"}},{"id":4368668,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":168845,"kind":"person","name":"Phalen Michael P.","position":1,"cik":"0001483882","reported_name":"Phalen Michael P.","relationship":{"officer":true,"officer_title":"EVP & President, MedSurg"}}],"security":"Stock Option (Right to Buy)","published_at":"2017-03-30T20:37:01.000Z","date":"2017-03-29","kind":"exercise","acquired":false,"shares":46500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 28, 2012, the first anniversary of the grant."}],"balance_after":139835,"derivative":{"exercise_price":7.16,"expiration_date":"2021-02-28","underlying":"Common Stock","underlying_shares":46500},"source":{"system":"sec-edgar","filing":"0001225208-17-007048","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520817007048/doc4.xml","form_type":"4"}},{"id":4368667,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":168845,"kind":"person","name":"Phalen Michael P.","position":1,"cik":"0001483882","reported_name":"Phalen Michael P.","relationship":{"officer":true,"officer_title":"EVP & President, MedSurg"}}],"security":"Common Stock","published_at":"2017-03-30T20:37:01.000Z","date":"2017-03-29","kind":"sale","acquired":false,"shares":79045,"price":24.5473,"value":1940341.3285,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares acquired under the Boston Scientific Global Employee Stock Purchase Plan based upon the most current data available."}],"balance_after":101919,"source":{"system":"sec-edgar","filing":"0001225208-17-007048","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520817007048/doc4.xml","form_type":"4"}},{"id":4368666,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":168845,"kind":"person","name":"Phalen Michael P.","position":1,"cik":"0001483882","reported_name":"Phalen Michael P.","relationship":{"officer":true,"officer_title":"EVP & President, MedSurg"}}],"security":"Common Stock","published_at":"2017-03-30T20:37:01.000Z","date":"2017-03-29","kind":"exercise","acquired":true,"shares":46500,"price":7.16,"value":332940.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares acquired under the Boston Scientific Global Employee Stock Purchase Plan based upon the most current data available."}],"balance_after":180964,"source":{"system":"sec-edgar","filing":"0001225208-17-007048","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520817007048/doc4.xml","form_type":"4"}},{"id":4415550,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":168845,"kind":"person","name":"Phalen Michael P.","position":1,"cik":"0001483882","reported_name":"Phalen Michael P.","relationship":{"officer":true,"officer_title":"EVP & President, MedSurg"}}],"security":"Stock Option (Right to Buy)","published_at":"2017-03-02T01:56:43.000Z","date":"2017-02-28","kind":"grant","acquired":true,"shares":39525,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F10","text":"Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 28, 2018, the first anniversary of the date of grant."}],"balance_after":39525,"derivative":{"exercise_price":24.55,"expiration_date":"2027-02-28","underlying":"Common Stock","underlying_shares":39525},"source":{"system":"sec-edgar","filing":"0001225208-17-005155","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520817005155/doc4.xml","form_type":"4"}},{"id":4415549,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":168845,"kind":"person","name":"Phalen Michael P.","position":1,"cik":"0001483882","reported_name":"Phalen Michael P.","relationship":{"officer":true,"officer_title":"EVP & President, MedSurg"}}],"security":"Performance Share Units","published_at":"2017-03-02T01:56:43.000Z","date":"2017-02-28","kind":"grant","acquired":true,"shares":14059,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F8","text":"Each performance share unit represents the Company's commitment to issue one share of Boston Scientific common stock."},{"field":"shares","element":"transactionShares","label":"F9","text":"On February 22, 2016, the reporting person was awarded a target number of performance share units under the Company's 2016 Free Cash Flow Performance Share Program, the actual number of which to be earned by the reporting person based on the Company's 2016 adjusted free cash flow measured against its 2016 financial plan over the one-year performance period ending December 31, 2016 and subject to the completion of a three-year individual service period (inclusive of the performance period). On February 28, 2017, the number of the target performance share units as to which the performance criteria had been satisfied was determined. The performance share units so determined will vest in whole upon the completion of the individual service period that ends on December 31, 2018."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F9","text":"On February 22, 2016, the reporting person was awarded a target number of performance share units under the Company's 2016 Free Cash Flow Performance Share Program, the actual number of which to be earned by the reporting person based on the Company's 2016 adjusted free cash flow measured against its 2016 financial plan over the one-year performance period ending December 31, 2016 and subject to the completion of a three-year individual service period (inclusive of the performance period). On February 28, 2017, the number of the target performance share units as to which the performance criteria had been satisfied was determined. The performance share units so determined will vest in whole upon the completion of the individual service period that ends on December 31, 2018."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F9","text":"On February 22, 2016, the reporting person was awarded a target number of performance share units under the Company's 2016 Free Cash Flow Performance Share Program, the actual number of which to be earned by the reporting person based on the Company's 2016 adjusted free cash flow measured against its 2016 financial plan over the one-year performance period ending December 31, 2016 and subject to the completion of a three-year individual service period (inclusive of the performance period). On February 28, 2017, the number of the target performance share units as to which the performance criteria had been satisfied was determined. The performance share units so determined will vest in whole upon the completion of the individual service period that ends on December 31, 2018."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F9","text":"On February 22, 2016, the reporting person was awarded a target number of performance share units under the Company's 2016 Free Cash Flow Performance Share Program, the actual number of which to be earned by the reporting person based on the Company's 2016 adjusted free cash flow measured against its 2016 financial plan over the one-year performance period ending December 31, 2016 and subject to the completion of a three-year individual service period (inclusive of the performance period). On February 28, 2017, the number of the target performance share units as to which the performance criteria had been satisfied was determined. The performance share units so determined will vest in whole upon the completion of the individual service period that ends on December 31, 2018."}],"balance_after":14059,"derivative":{"exercise_date":"2018-12-31","expiration_date":"2018-12-31","underlying":"Common Stock","underlying_shares":14059},"source":{"system":"sec-edgar","filing":"0001225208-17-005155","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520817005155/doc4.xml","form_type":"4"}},{"id":4415548,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":168845,"kind":"person","name":"Phalen Michael P.","position":1,"cik":"0001483882","reported_name":"Phalen Michael P.","relationship":{"officer":true,"officer_title":"EVP & President, MedSurg"}}],"security":"Deferred Stock Units","published_at":"2017-03-02T01:56:43.000Z","date":"2017-02-28","kind":"grant","acquired":true,"shares":12219,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"Shares of common stock will be issued to the reporting person in five equal annual installments beginning on February 28, 2018, the first anniversary of the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"Shares of common stock will be issued to the reporting person in five equal annual installments beginning on February 28, 2018, the first anniversary of the date of grant."}],"balance_after":12219,"derivative":{"expiration_date":"2022-02-28","underlying":"Common Stock","underlying_shares":12219},"source":{"system":"sec-edgar","filing":"0001225208-17-005155","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520817005155/doc4.xml","form_type":"4"}},{"id":4415547,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":168845,"kind":"person","name":"Phalen Michael P.","position":1,"cik":"0001483882","reported_name":"Phalen Michael P.","relationship":{"officer":true,"officer_title":"EVP & President, MedSurg"}}],"security":"Deferred Stock Units","published_at":"2017-03-02T01:56:43.000Z","date":"2017-02-28","kind":"exercise","acquired":false,"shares":5413,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Shares of common stock will be issued to the reporting person in five equal annual installments beginning on February 28, 2014, the first anniversary of the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Shares of common stock will be issued to the reporting person in five equal annual installments beginning on February 28, 2014, the first anniversary of the date of grant."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F6","text":"Reflects multiple DSU awards with independent vesting schedules."}],"balance_after":5413,"derivative":{"underlying":"Common Stock","underlying_shares":5413},"source":{"system":"sec-edgar","filing":"0001225208-17-005155","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520817005155/doc4.xml","form_type":"4"}},{"id":4415546,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":168845,"kind":"person","name":"Phalen Michael P.","position":1,"cik":"0001483882","reported_name":"Phalen Michael P.","relationship":{"officer":true,"officer_title":"EVP & President, MedSurg"}}],"security":"Common Stock","published_at":"2017-03-02T01:56:43.000Z","date":"2017-02-28","kind":"tax_withholding","acquired":false,"shares":17214,"price":24.55,"value":422603.7,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares acquired under the Boston Scientific Global Employee Stock Purchase Plan based upon the most current data available."}],"balance_after":134464,"source":{"system":"sec-edgar","filing":"0001225208-17-005155","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520817005155/doc4.xml","form_type":"4"}},{"id":4415545,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":168845,"kind":"person","name":"Phalen Michael P.","position":1,"cik":"0001483882","reported_name":"Phalen Michael P.","relationship":{"officer":true,"officer_title":"EVP & President, MedSurg"}}],"security":"Common Stock","published_at":"2017-03-02T01:56:43.000Z","date":"2017-02-28","kind":"exercise","acquired":true,"shares":5413,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares acquired under the Boston Scientific Global Employee Stock Purchase Plan based upon the most current data available."}],"balance_after":151678,"source":{"system":"sec-edgar","filing":"0001225208-17-005155","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520817005155/doc4.xml","form_type":"4"}},{"id":4415544,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":168845,"kind":"person","name":"Phalen Michael P.","position":1,"cik":"0001483882","reported_name":"Phalen Michael P.","relationship":{"officer":true,"officer_title":"EVP & President, MedSurg"}}],"security":"Common Stock","published_at":"2017-03-02T01:56:43.000Z","date":"2017-02-28","kind":"grant","acquired":true,"shares":34402,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On February 24, 2014, the reporting person was awarded a target number of performance share units under the Company's 2014 Total Shareholder Return Performance Share Program, the actual number of which to be earned by the reporting person was based on the Company's total shareholder return performance percentile relative to that of the other companies in the S&P 500 Healthcare Index over the three annual performance cycles comprising the three-year period ended December 31, 2016 and was subject to the completion of the concurrent three-year individual service period. On February 28, 2017, the number of the target performance share units as to which the performance criteria had been satisfied was determined and the individual service period was satisfied."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares acquired under the Boston Scientific Global Employee Stock Purchase Plan based upon the most current data available."}],"balance_after":146265,"source":{"system":"sec-edgar","filing":"0001225208-17-005155","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520817005155/doc4.xml","form_type":"4"}},{"id":4419246,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":168845,"kind":"person","name":"Phalen Michael P.","position":1,"cik":"0001483882","reported_name":"Phalen Michael P.","relationship":{"officer":true,"officer_title":"EVP & President, MedSurg"}}],"security":"Deferred Stock Units","published_at":"2017-02-28T21:46:23.000Z","date":"2017-02-27","kind":"exercise","acquired":false,"shares":6370,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Shares of common stock will be issued to the reporting person in five equal annual installments beginning on February 27, 2013, the first anniversary of the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Shares of common stock will be issued to the reporting person in five equal annual installments beginning on February 27, 2013, the first anniversary of the date of grant."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F5","text":"Reflects multiple DSU awards with independent vesting schedules."}],"balance_after":10826,"derivative":{"underlying":"Common Stock","underlying_shares":6370},"source":{"system":"sec-edgar","filing":"0001225208-17-004926","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520817004926/doc4.xml","form_type":"4"}},{"id":4419245,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":168845,"kind":"person","name":"Phalen Michael P.","position":1,"cik":"0001483882","reported_name":"Phalen Michael P.","relationship":{"officer":true,"officer_title":"EVP & President, MedSurg"}}],"security":"Common Stock","published_at":"2017-02-28T21:46:23.000Z","date":"2017-02-27","kind":"tax_withholding","acquired":false,"shares":2068,"price":24.81,"value":51307.08,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares acquired under the Boston Scientific Global Employee Stock Purchase Plan based upon the most current data available."}],"balance_after":111863,"source":{"system":"sec-edgar","filing":"0001225208-17-004926","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520817004926/doc4.xml","form_type":"4"}},{"id":4419244,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":168845,"kind":"person","name":"Phalen Michael P.","position":1,"cik":"0001483882","reported_name":"Phalen Michael P.","relationship":{"officer":true,"officer_title":"EVP & President, MedSurg"}}],"security":"Common Stock","published_at":"2017-02-28T21:46:23.000Z","date":"2017-02-27","kind":"exercise","acquired":true,"shares":6370,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares acquired under the Boston Scientific Global Employee Stock Purchase Plan based upon the most current data available."}],"balance_after":113931,"source":{"system":"sec-edgar","filing":"0001225208-17-004926","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520817004926/doc4.xml","form_type":"4"}},{"id":4422919,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":168845,"kind":"person","name":"Phalen Michael P.","position":1,"cik":"0001483882","reported_name":"Phalen Michael P.","relationship":{"officer":true,"officer_title":"EVP & President, MedSurg"}}],"security":"Deferred Stock Units","published_at":"2017-02-27T21:30:38.000Z","date":"2017-02-24","kind":"exercise","acquired":false,"shares":3440,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Shares of common stock will be issued to the reporting person in five equal annual installments beginning on February 24, 2015, the first anniversary of the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Shares of common stock will be issued to the reporting person in five equal annual installments beginning on February 24, 2015, the first anniversary of the date of grant."}],"balance_after":6881,"derivative":{"exercise_price":0,"expiration_date":"2019-02-24","underlying":"Common Stock","underlying_shares":3440},"source":{"system":"sec-edgar","filing":"0001225208-17-004742","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520817004742/doc4.xml","form_type":"4"}},{"id":4422918,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":168845,"kind":"person","name":"Phalen Michael P.","position":1,"cik":"0001483882","reported_name":"Phalen Michael P.","relationship":{"officer":true,"officer_title":"EVP & President, MedSurg"}}],"security":"Common Stock","published_at":"2017-02-27T21:30:38.000Z","date":"2017-02-24","kind":"tax_withholding","acquired":false,"shares":1117,"price":24.78,"value":27679.26,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares acquired under the Boston Scientific Global Employee Stock Purchase Plan based upon the most current data available."}],"balance_after":107561,"source":{"system":"sec-edgar","filing":"0001225208-17-004742","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520817004742/doc4.xml","form_type":"4"}},{"id":4422917,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":168845,"kind":"person","name":"Phalen Michael P.","position":1,"cik":"0001483882","reported_name":"Phalen Michael P.","relationship":{"officer":true,"officer_title":"EVP & President, MedSurg"}}],"security":"Common Stock","published_at":"2017-02-27T21:30:38.000Z","date":"2017-02-24","kind":"exercise","acquired":true,"shares":3440,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares acquired under the Boston Scientific Global Employee Stock Purchase Plan based upon the most current data available."}],"balance_after":108678,"source":{"system":"sec-edgar","filing":"0001225208-17-004742","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520817004742/doc4.xml","form_type":"4"}},{"id":4425787,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":168845,"kind":"person","name":"Phalen Michael P.","position":1,"cik":"0001483882","reported_name":"Phalen Michael P.","relationship":{"officer":true,"officer_title":"EVP & President, MedSurg"}}],"security":"Deferred Stock Units","published_at":"2017-02-24T22:22:59.000Z","date":"2017-02-23","kind":"exercise","acquired":false,"shares":2452,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Shares of common stock will be issued to the reporting person in five equal annual installments beginning on February 23, 2016, the first anniversary of the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Shares of common stock will be issued to the reporting person in five equal annual installments beginning on February 23, 2016, the first anniversary of the date of grant."}],"balance_after":7358,"derivative":{"expiration_date":"2020-02-23","underlying":"Common Stock","underlying_shares":2452},"source":{"system":"sec-edgar","filing":"0001225208-17-004608","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520817004608/doc4.xml","form_type":"4"}},{"id":4425786,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":168845,"kind":"person","name":"Phalen Michael P.","position":1,"cik":"0001483882","reported_name":"Phalen Michael P.","relationship":{"officer":true,"officer_title":"EVP & President, MedSurg"}}],"security":"Common Stock","published_at":"2017-02-24T22:22:59.000Z","date":"2017-02-23","kind":"tax_withholding","acquired":false,"shares":796,"price":24.48,"value":19486.08,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares acquired under the Boston Scientific Global Employee Stock Purchase Plan based upon the most current data available."}],"balance_after":105238,"source":{"system":"sec-edgar","filing":"0001225208-17-004608","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520817004608/doc4.xml","form_type":"4"}},{"id":4425785,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":168845,"kind":"person","name":"Phalen Michael P.","position":1,"cik":"0001483882","reported_name":"Phalen Michael P.","relationship":{"officer":true,"officer_title":"EVP & President, MedSurg"}}],"security":"Common Stock","published_at":"2017-02-24T22:22:59.000Z","date":"2017-02-23","kind":"exercise","acquired":true,"shares":2452,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares acquired under the Boston Scientific Global Employee Stock Purchase Plan based upon the most current data available."}],"balance_after":106034,"source":{"system":"sec-edgar","filing":"0001225208-17-004608","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520817004608/doc4.xml","form_type":"4"}},{"id":4428907,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":168845,"kind":"person","name":"Phalen Michael P.","position":1,"cik":"0001483882","reported_name":"Phalen Michael P.","relationship":{"officer":true,"officer_title":"EVP & President, MedSurg"}}],"security":"Deferred Stock Units","published_at":"2017-02-23T23:41:48.000Z","date":"2017-02-22","kind":"exercise","acquired":false,"shares":2462,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Shares of common stock will be issued to the reporting person in five equal annual installments beginning on February 22, 2017, the first anniversary of the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Shares of common stock will be issued to the reporting person in five equal annual installments beginning on February 22, 2017, the first anniversary of the date of grant."}],"balance_after":9849,"derivative":{"expiration_date":"2021-02-22","underlying":"Common Stock","underlying_shares":2462},"source":{"system":"sec-edgar","filing":"0001225208-17-004434","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520817004434/doc4.xml","form_type":"4"}},{"id":4428906,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":168845,"kind":"person","name":"Phalen Michael P.","position":1,"cik":"0001483882","reported_name":"Phalen Michael P.","relationship":{"officer":true,"officer_title":"EVP & President, MedSurg"}}],"security":"Common Stock","published_at":"2017-02-23T23:41:48.000Z","date":"2017-02-22","kind":"tax_withholding","acquired":false,"shares":799,"price":25.16,"value":20102.84,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares acquired under the Boston Scientific Global Employee Stock Purchase Plan based upon the most current data available."}],"balance_after":103582,"source":{"system":"sec-edgar","filing":"0001225208-17-004434","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520817004434/doc4.xml","form_type":"4"}},{"id":4428905,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":168845,"kind":"person","name":"Phalen Michael P.","position":1,"cik":"0001483882","reported_name":"Phalen Michael P.","relationship":{"officer":true,"officer_title":"EVP & President, MedSurg"}}],"security":"Common Stock","published_at":"2017-02-23T23:41:48.000Z","date":"2017-02-22","kind":"exercise","acquired":true,"shares":2462,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares acquired under the Boston Scientific Global Employee Stock Purchase Plan based upon the most current data available."}],"balance_after":104381,"source":{"system":"sec-edgar","filing":"0001225208-17-004434","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520817004434/doc4.xml","form_type":"4"}},{"id":4504920,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":168845,"kind":"person","name":"Phalen Michael P.","position":1,"cik":"0001483882","reported_name":"Phalen Michael P.","relationship":{"officer":true,"officer_title":"EVP & President, MedSurg"}}],"security":"Performance Share Units","published_at":"2017-01-04T21:40:08.000Z","date":"2017-01-01","kind":"exercise","acquired":false,"shares":17510,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each performance share unit represents the Company's commitment to issue one share of Boston Scientific common stock."},{"field":"shares","element":"transactionShares","label":"F1","text":"On February 24, 2014, the reporting person was awarded a target number of performance share units under the Company's 2014 Free Cash Flow Performance Share Program, the actual number of which to be earned by the reporting person based on the Company's 2014 adjusted free cash flow measured against its 2014 financial plan over the one-year performance period ending December 31, 2014 and subject to the completion of a three-year individual service period (inclusive of the performance period). On February 23, 2015, the number of the target performance share units as to which the performance criteria had been satisfied was determined. The performance share units so determined vested in whole upon the completion of the individual service period that ended on December 31, 2016."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On February 24, 2014, the reporting person was awarded a target number of performance share units under the Company's 2014 Free Cash Flow Performance Share Program, the actual number of which to be earned by the reporting person based on the Company's 2014 adjusted free cash flow measured against its 2014 financial plan over the one-year performance period ending December 31, 2014 and subject to the completion of a three-year individual service period (inclusive of the performance period). On February 23, 2015, the number of the target performance share units as to which the performance criteria had been satisfied was determined. The performance share units so determined vested in whole upon the completion of the individual service period that ended on December 31, 2016."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"On February 24, 2014, the reporting person was awarded a target number of performance share units under the Company's 2014 Free Cash Flow Performance Share Program, the actual number of which to be earned by the reporting person based on the Company's 2014 adjusted free cash flow measured against its 2014 financial plan over the one-year performance period ending December 31, 2014 and subject to the completion of a three-year individual service period (inclusive of the performance period). On February 23, 2015, the number of the target performance share units as to which the performance criteria had been satisfied was determined. The performance share units so determined vested in whole upon the completion of the individual service period that ended on December 31, 2016."}],"balance_after":0,"derivative":{"exercise_date":"2016-12-31","expiration_date":"2016-12-31","underlying":"Common Stock","underlying_shares":17510},"source":{"system":"sec-edgar","filing":"0001225208-17-000412","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520817000412/doc4.xml","form_type":"4"}},{"id":4504919,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":168845,"kind":"person","name":"Phalen Michael P.","position":1,"cik":"0001483882","reported_name":"Phalen Michael P.","relationship":{"officer":true,"officer_title":"EVP & President, MedSurg"}}],"security":"Common Stock","published_at":"2017-01-04T21:40:08.000Z","date":"2017-01-01","kind":"tax_withholding","acquired":false,"shares":5964,"price":21.63,"value":129001.32,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares acquired under the Boston Scientific Global Employee Stock Purchase Plan based upon the most current data available."}],"balance_after":101632,"source":{"system":"sec-edgar","filing":"0001225208-17-000412","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520817000412/doc4.xml","form_type":"4"}},{"id":4504918,"issuer":{"id":1897,"kind":"organization","name":"BOSTON SCIENTIFIC CORP","symbol":"BSX"},"owners":[{"id":168845,"kind":"person","name":"Phalen Michael P.","position":1,"cik":"0001483882","reported_name":"Phalen Michael P.","relationship":{"officer":true,"officer_title":"EVP & President, MedSurg"}}],"security":"Common Stock","published_at":"2017-01-04T21:40:08.000Z","date":"2017-01-01","kind":"exercise","acquired":true,"shares":17510,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On February 24, 2014, the reporting person was awarded a target number of performance share units under the Company's 2014 Free Cash Flow Performance Share Program, the actual number of which to be earned by the reporting person based on the Company's 2014 adjusted free cash flow measured against its 2014 financial plan over the one-year performance period ending December 31, 2014 and subject to the completion of a three-year individual service period (inclusive of the performance period). On February 23, 2015, the number of the target performance share units as to which the performance criteria had been satisfied was determined. The performance share units so determined vested in whole upon the completion of the individual service period that ended on December 31, 2016."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares acquired under the Boston Scientific Global Employee Stock Purchase Plan based upon the most current data available."}],"balance_after":107596,"source":{"system":"sec-edgar","filing":"0001225208-17-000412","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/885725/000122520817000412/doc4.xml","form_type":"4"}}]}